Efficiency and safety of oxcarbazepine in mood disorders: A naturalistic study exploring the interest of plasma dosages

European Psychiatry

Volumn 23, Issue 6, 2008, Pages 409-412

  Misdrahi, David ^a   Tournier, Marie ^a,b   Droulout, Tiphaine ^a   Grolleau, Adeline ^b   Titier, Karine ^b   Molimard, Mathieu ^b   Verdoux, Helene ^a,b  

^a CENTRE HOSPITALIER CHARLES PERRENS   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Anticonvulsants; Bipolar disorder; Oxcarbazepine

Indexed keywords

AMISULPRIDE; ANXIOLYTIC AGENT; BENZODIAZEPINE; CYAMEMAZINE; DOXYCYCLINE; DRUG METABOLITE; HYDROXYOXCARBAZEPINE; LITHIUM; LORATADINE; NEUROLEPTIC AGENT; OXCARBAZEPINE; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG; VALPROIC ACID;

ABDOMINAL PAIN; ACNE; ADOLESCENT; ADULT; ALOPECIA; AMNESIA; ARTICLE; BIPOLAR DISORDER; BLOOD SAMPLING; BLURRED VISION; CLINICAL ARTICLE; CLINICAL PRACTICE; CONCENTRATION LOSS; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DIPLOPIA; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEADACHE; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPONATREMIA; LIVER FUNCTION; MALE; MEDICAL RECORD REVIEW; MOOD DISORDER; NAUSEA; NYSTAGMUS; PATIENT IDENTIFICATION; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SIDE EFFECT; SKIN MANIFESTATION; SOMNOLENCE; TREMOR;

ADOLESCENT; ADULT; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ERUPTIONS; DRUG THERAPY, COMBINATION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PATIENT DROPOUTS; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 51449096208     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2008.05.003     Document Type: Article

References (18)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. (1994), American Psychiatric Press, Washington
2. American Psychiatric Association (APA). Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 159 (2002) 1-50
3. Bech P., Rafaelsen O.J., Kramp P., and Bolwig T.G. The mania rating scale: scale construction and inter-observer agreement. Neuropharmacology 17 (1978) 430-431
4. Benedetti A., Lattanzi L., Pini S., Musetti L., Dell'Osso L., and Cassano G.B. Oxcarbazepine as add-on treatment in patients with bipolar manic, mixed or depressive episode. J Affect Disord 79 (2004) 273-277
5. Centorrino F., Albert M.J., Berry J.M., Kelleher J.P., Fellman V., Line G., et al. Oxcarbazepine: clinical experience with hospitalized psychiatric patients. Bipolar Disord 5 (2003) 370-374
6. Emrich H.M. Studies with oxcarbazepine (Trileptal) in acute mania. Int Clin Psychopharmacol 5 (1990) 83-88
7. Ghaemi S.N., Berv D.A., Klugman J., Rosenquist K.J., and Hsu D.J. Oxcarbazepine treatment of bipolar disorder. J Clin Psychiatry 64 (2003) 943-945
8. Hellewell J.S. Oxcarbazepine (Trileptal) in the treatment of bipolar disorders: a review of efficacy and tolerability. J Affect Disord 72 Suppl. 1 (2002) S23-S34
9. Hummel B., Walden J., Stampfer R., Dittmann S., Amann B., Sterr A., et al. Acute antimanic efficacy and safety of oxcarbazepine in an open trial with an on-off-on design. Bipolar Disord 4 (2002) 412-417
10. Johannessen S.I., Battino D., Berry D.J., Bialer M., Kramer G., Tomson T., et al. Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25 (2003) 347-363
11. Lingjaerde O., Ahlfors U.G., Bech P., Dencker S.J., and Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side-effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 334 (1987) 1-100
12. Lloyd P., Flesch G., and Dieterle W. Clinical pharmacology and pharmacokinetics of oxcarbazepine. Epilepsia 35 Suppl. 3 (1994) S10-S13
13. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 134 (1979) 382-389
14. Pratoomsri W., Yatham L.N., Bond D.J., Lam R.W., and Sohn C.H. Oxcarbazepine in the treatment of bipolar disorder: a review. Can J Psychiatry 51 (2006) 540-545
15. Pratoomsri W., Yatham L.N., Sohn C.H., Solomons K., and Lam R.W. Oxcarbazepine add-on in the treatment of refractory bipolar disorder. Bipolar Disord 7 Suppl. 5 (2005) 37-42
16. Stata Corporation. Stata statistical software: release 8.0, user's guide (2005), Stata Press, College Station
17. Suppes T., Dennehy E.B., Hirschfeld R.M., Altshuler L.L., Bowden C.L., Calabrese J.R., et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder. J Clin Psychiatry 66 (2005) 870-886
18. Wang P.W., and Ketter T.A. Pharmacokinetics of mood stabilizers and new anticonvulsants. Psychopharmacol Bull 36 (2002) 44-66